Botox Drug Use Investigation (Spasmodic Dysphonia)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dysphonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.
- 04 Jun 2018 New trial record